BUFENCON INJECTION 5ML VIAL

Manufacturer
YUNG SHIN PHARMACEUTICAL IND. CO., LTD.(TAIWAN)

Registraction Number
MAL19940638AZ

Content:
Bufencon Injection 5ml Vial contains the active ingredients betamethasone sodium phosphate and betamethasone dipropionate. Each mL of the solution contains 2.63 mg of betamethasone sodium phosphate (equivalent to 2.0 mg of betamethasone) and 6.43 mg of betamethasone dipropionate (equivalent to 5.0 mg of betamethasone)2.
Indications:
Bufencon Injection is used for the treatment of:
Musculoskeletal and Soft Tissue Conditions: Rheumatoid arthritis, osteoarthritis, bursitis, ankylosing spondylitis, epicondylitis, radiculitis, coccydynia, sciatica, lumbago, torticollis, ganglion cyst, exostosis, fasciitis.
Allergic Conditions: Chronic bronchial asthma, hay fever, angioneurotic edema, allergic bronchitis, seasonal or perennial allergic rhinitis, drug reactions, serum sickness, insect bites.
Instructions:
Dosage: Follow the dosage prescribed by your doctor. The dosage varies depending on the condition being treated.
Administration:
For intramuscular, intra-articular, intradermal, or intralesional injection only.
Ensure the immediate availability of oxygen and other resuscitative equipment when administering the injection.
Missed Dose: This medication is typically administered by a healthcare professional in a clinical setting, so missed doses are not common.